1. Home
  2. TOI vs GNE Comparison

TOI vs GNE Comparison

Compare TOI & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOI
  • GNE
  • Stock Information
  • Founded
  • TOI 2007
  • GNE 2011
  • Country
  • TOI United States
  • GNE United States
  • Employees
  • TOI N/A
  • GNE N/A
  • Industry
  • TOI Medical/Nursing Services
  • GNE Power Generation
  • Sector
  • TOI Health Care
  • GNE Utilities
  • Exchange
  • TOI Nasdaq
  • GNE Nasdaq
  • Market Cap
  • TOI 444.1M
  • GNE 407.6M
  • IPO Year
  • TOI N/A
  • GNE N/A
  • Fundamental
  • Price
  • TOI $3.56
  • GNE $14.86
  • Analyst Decision
  • TOI Strong Buy
  • GNE
  • Analyst Count
  • TOI 2
  • GNE 0
  • Target Price
  • TOI $6.50
  • GNE N/A
  • AVG Volume (30 Days)
  • TOI 2.3M
  • GNE 107.3K
  • Earning Date
  • TOI 11-13-2025
  • GNE 11-03-2025
  • Dividend Yield
  • TOI N/A
  • GNE 2.02%
  • EPS Growth
  • TOI N/A
  • GNE 49.43
  • EPS
  • TOI N/A
  • GNE 0.18
  • Revenue
  • TOI $424,376,000.00
  • GNE $483,284,000.00
  • Revenue This Year
  • TOI $21.71
  • GNE $14.60
  • Revenue Next Year
  • TOI $20.58
  • GNE $8.64
  • P/E Ratio
  • TOI N/A
  • GNE $81.45
  • Revenue Growth
  • TOI 17.53
  • GNE 13.12
  • 52 Week Low
  • TOI $0.13
  • GNE $13.05
  • 52 Week High
  • TOI $4.88
  • GNE $28.47
  • Technical
  • Relative Strength Index (RSI)
  • TOI 34.96
  • GNE 43.60
  • Support Level
  • TOI $4.49
  • GNE $13.56
  • Resistance Level
  • TOI $4.62
  • GNE $15.13
  • Average True Range (ATR)
  • TOI 0.31
  • GNE 0.57
  • MACD
  • TOI -0.12
  • GNE -0.04
  • Stochastic Oscillator
  • TOI 10.82
  • GNE 56.90

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

About GNE Genie Energy Ltd. Class B Stock

Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.

Share on Social Networks: